» Articles » PMID: 33459858

Implications of US Radiomics Signature for Predicting Malignancy in Thyroid Nodules with Indeterminate Cytology

Overview
Journal Eur Radiol
Specialty Radiology
Date 2021 Jan 18
PMID 33459858
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to evaluate the role of the radiomics score using US images to predict malignancy in AUS/FLUS and FN/SFN nodules.

Methods: One hundred fifty-five indeterminate thyroid nodules in 154 patients who received initial US-guided FNA for diagnostic purposes were included in this retrospective study. A representative US image of each tumor was acquired, and square ROIs covering the whole nodule were drawn using the Paint program of Windows 7. Texture features were extracted by in-house texture analysis algorithms implemented in MATLAB 2019b. The LASSO logistic regression model was used to choose the most useful predictive features, and ten-fold cross-validation was performed. Two prediction models were constructed using multivariable logistic regression analysis: one based on clinical variables, and the other based on clinical variables with the radiomics score. Predictability of the two models was assessed with the AUC of the ROC curves.

Results: Clinical characteristics did not significantly differ between malignant and benign nodules, except for mean nodule size. Among 730 candidate texture features generated from a single US image, 15 features were selected. Radiomics signatures were constructed with a radiomics score, using selected features. In multivariable logistic regression analysis, higher radiomics score was associated with malignancy (OR = 10.923; p < 0.001). The AUC of the malignancy prediction model composed of clinical variables with the radiomics score was significantly higher than the model composed of clinical variables alone (0.839 vs 0.583).

Conclusions: Quantitative US radiomics features can help predict malignancy in thyroid nodules with indeterminate cytology.

Citing Articles

Intranodular and perinodular ultrasound radiomics distinguishes benign and malignant thyroid nodules: a multicenter study.

Zhu X, Li J, Li H, Wang K, Zhang J, Meng J Gland Surg. 2025; 13(12):2359-2371.

PMID: 39822358 PMC: 11733639. DOI: 10.21037/gs-24-416.


Combined model integrating clinical, radiomics, BRAF and ultrasound for differentiating between benign and malignant indeterminate cytology (Bethesda III) thyroid nodules: a bi-center retrospective study.

Zhong L, Shi L, Lai J, Hu Y, Gu L Gland Surg. 2024; 13(11):1954-1964.

PMID: 39678423 PMC: 11635559. DOI: 10.21037/gs-24-310.


Combining radiomics with thyroid imaging reporting and data system to predict lateral cervical lymph node metastases in medullary thyroid cancer.

Liu Z, Zhang X, Zhao X, Guo Q, Li Z, Wei M BMC Med Imaging. 2024; 24(1):64.

PMID: 38500053 PMC: 10946103. DOI: 10.1186/s12880-024-01222-7.


Dual-modal radiomics nomogram based on contrast-enhanced ultrasound to improve differential diagnostic accuracy and reduce unnecessary biopsy rate in ACR TI-RADS 4-5 thyroid nodules.

Ren J, Lv W, Wang L, Zhang W, Ma Y, Huang Y Cancer Imaging. 2024; 24(1):17.

PMID: 38263209 PMC: 10807093. DOI: 10.1186/s40644-024-00661-3.


The progress of radiomics in thyroid nodules.

Gao X, Ran X, Ding W Front Oncol. 2023; 13:1109319.

PMID: 36959790 PMC: 10029726. DOI: 10.3389/fonc.2023.1109319.


References
1.
VANDER J, Gaston E, DAWBER T . The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med. 1968; 69(3):537-40. DOI: 10.7326/0003-4819-69-3-537. View

2.
Tan G, Gharib H . Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997; 126(3):226-31. DOI: 10.7326/0003-4819-126-3-199702010-00009. View

3.
Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

4.
Cibas E, Ali S . The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11):1341-1346. DOI: 10.1089/thy.2017.0500. View

5.
Yoon J, Moon H, Kim E, Kwak J . Inadequate cytology in thyroid nodules: should we repeat aspiration or follow-up?. Ann Surg Oncol. 2011; 18(5):1282-9. DOI: 10.1245/s10434-011-1605-7. View